Fundraising FoxNeXtGen Biologics
Alachua, US · Founded 2014 · Delaware corporation
Find your way into NeXtGen Biologics
Sign up to see every warm intro you have to NeXtGen Biologics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NeXtGen Biologics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JT
Jonelle ToothmanExecutiveJonelle Toothman is executive officer and director of NeXtGen Biologics, a regenerative medicine company that develops an extracellular matrix platform derived from axolotl biology for medical devices, pharmaceuticals, and other therapeutic applications.
JG
Jamie GroomsNamed on SEC filing
Board
DH
Dan HamisterBoard director
BL
Brian LipkeBoard director
EL
Elad LevyBoard director
RW
Rick WasselBoard director
GK
Gerald KluftBoard director
Reported raises · per SEC filings
Form D private placements$2.9M disclosed across 4 of 6 rounds · 2014–2025
▶$130KraisedSep 2025 · 3 investors · BiotechnologyRule 506(b)
▶$130KraisedSep 2025 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Elad LevyDirector
- Rick WasselDirector
- Gerald KluftDirector
- Jonelle ToothmanExecutive Officer, Director
- Jamie GroomsDirector
- Dan HamisterDirector
- Brian LipkeDirector
- Offering amount
- $5M
- Amount sold
- $130K
- Minimum investment
- $30K
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100KraisedAug 2020 · 1 investors · BiotechnologyRule 506(b)
▶$100KraisedAug 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonelle ToothmanExecutive Officer, Director
- Amount sold
- $100K
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedDec 2018 · 19 investors · BiotechnologyRule 506(c)
▶$2.2MraisedDec 2018 · 19 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Elad LevyDirector
- Mark HamisterDirector
- Jonelle ToothmanExecutive Officer, Director
- Gerald KluftDirector
- Rick WasselDirector
- Jamie GroomsDirector
- Mark GoldDirector
- Amount sold
- $2.2M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06c
▶Undisclosed amountofferedMay 2017 · BiotechnologyRule 506(b)
▶Undisclosed amountofferedMay 2017 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonelle ToothmanExecutive Officer, Director
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1.5MofferedNov 2015 · BiotechnologyRule 506(b)
▶$1.5MofferedNov 2015 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonelle ToothmanExecutive Officer, Director
- Offering amount
- $1.5M
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$500KraisedSep 2014 · 2 investors · BiotechnologyRule 506(b)
▶$500KraisedSep 2014 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jamie GroomsExecutive Officer, Director
- Jonelle ToothmanExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $500K
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has NeXtGen Biologics raised?
- NeXtGen Biologics has disclosed $2.9M raised across 4 of its 6 known rounds.
- Where is NeXtGen Biologics headquartered?
- NeXtGen Biologics is headquartered in Alachua, US.